Ignite Creation Date:
2025-12-24 @ 3:58 PM
Ignite Modification Date:
2025-12-28 @ 4:09 PM
Study NCT ID:
NCT05763992
Status:
RECRUITING
Last Update Posted:
2023-05-18
First Post:
2023-01-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Targeting Triple Negative BREAst Cancer Metabolism With a Combination of Chemoimmunotherapy and a FASTing-like Approach in the Preoperative Setting: the BREAKFAST 2 Trial
Sponsor:
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-05-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-05-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-05-15
Completion Date Type:
ESTIMATED
First Submit Date:
2023-01-18
First Submit QC Date:
None
Study First Post Date:
2023-03-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-16
Last Update Post Date:
2023-05-18
Last Update Post Date Type:
ACTUAL